Search Results

There are 5717 results for: content related to: Intermittent versus continuous erlotinib with concomitant modified “XELOX” (q3W) in first-line treatment of metastatic colorectal cancer

  1. You have free access to this content
    Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer

    Cancer

    Volume 120, Issue 15, August 1, 2014, Pages: 2289–2298, Adrian G. Sacher, Pasi A. Jänne and Geoffrey R. Oxnard

    Article first published online : 17 APR 2014, DOI: 10.1002/cncr.28723

  2. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date

    Cancer

    Volume 121, Issue 4, February 15, 2015, Pages: 502–516, Jayson I. L. Bastien, Katharine A. McNeill and Howard A. Fine

    Article first published online : 23 SEP 2014, DOI: 10.1002/cncr.28968

  3. Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib

    Cancer

    Jarushka Naidoo, Camelia S. Sima, Katherine Rodriguez, Natalie Busby, Khedoudja Nafa, Marc Ladanyi, Gregory J. Riely, Mark G. Kris, Maria E. Arcila and Helena A. Yu

    Article first published online : 10 JUN 2015, DOI: 10.1002/cncr.29493

  4. You have free access to this content
    Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

    Cancer

    Volume 119, Issue 15, 1 August 2013, Pages: 2754–2764, Athanasios Karampeazis, Alexandra Voutsina, John Souglakos, Nikos Kentepozidis, Stelios Giassas, Charalambos Christofillakis, Athanasios Kotsakis, Pavlos Papakotoulas, Ageliki Rapti, Maria Agelidou, Sofia Agelaki, Lambros Vamvakas, George Samonis, Dimitris Mavroudis and Vassilis Georgoulias

    Article first published online : 9 MAY 2013, DOI: 10.1002/cncr.28132

  5. You have free access to this content
    A randomized phase 2 trial of erlotinib versus pemetrexed as second-line therapy in the treatment of patients with advanced EGFR wild-type and EGFR FISH-positive lung adenocarcinoma

    Cancer

    Volume 120, Issue 9, 1 May 2014, Pages: 1379–1386, Ning Li, Wei Ou, Hua Yang, Qian-Wen Liu, Song-Liang Zhang, Bao-Xiao Wang and Si-Yu Wang

    Article first published online : 30 JAN 2014, DOI: 10.1002/cncr.28591

  6. You have free access to this content
    Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy

    Cancer

    Volume 119, Issue 21, 1 November 2013, Pages: 3761–3768, Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin, Nikhil H. Ramaiya, Hiroto Hatabu, Pasi A. Jänne and Bruce E. Johnson

    Article first published online : 6 AUG 2013, DOI: 10.1002/cncr.28290

  7. You have full text access to this OnlineOpen article
    A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non–small cell lung cancer after failure of prior chemotherapy and erlotinib

    Cancer

    Volume 120, Issue 8, 15 April 2014, Pages: 1145–1154, Karen L. Reckamp, Giuseppe Giaccone, D. Ross Camidge, Shirish M. Gadgeel, Fadlo R. Khuri, Jeff A. Engelman, Marianna Koczywas, Arun Rajan, Alicyn K. Campbell, Diana Gernhardt, Ana Ruiz-Garcia, Stephen Letrent, Jane Liang, Ian Taylor, Joseph P. O'Connell and Pasi A. Jänne

    Article first published online : 5 FEB 2014, DOI: 10.1002/cncr.28561

  8. You have free access to this content
    Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations

    Cancer

    Volume 120, Issue 14, 15 July 2014, Pages: 2090–2098, Youngjoo Lee, Geon Kook Lee, Yeon-Su Lee, Wenji Zhang, Jung-Ah Hwang, Byung-Ho Nam, Seok Hyun Kim, Joo-Hang Kim, Tak Yun, Ji-Youn Han, Heung Tae Kim and Jin Soo Lee

    Article first published online : 15 APR 2014, DOI: 10.1002/cncr.28711

  9. Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)

    Cancer

    Volume 120, Issue 19, October 1, 2014, Pages: 2980–2985, Philip A. Philip, Bryan Goldman, Ramesh K. Ramanathan, Heinz-Josef Lenz, Andrew M. Lowy, Robert P. Whitehead, Takeru Wakatsuki, Syma Iqbal, Rakesh Gaur, Jacqueline K. Benedetti and Charles D. Blanke

    Article first published online : 16 JUL 2014, DOI: 10.1002/cncr.28744

  10. You have free access to this content
    Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer

    Cancer

    Volume 120, Issue 8, 15 April 2014, Pages: 1187–1193, Angelica Nogueira-Rodrigues, Giulliana Moralez, Rachele Grazziotin, Claudio C. Carmo, Isabele A. Small, Flavia V.G. Alves, Marcelo Mamede, Felipe Erlich, Celia Viegas, Sergio A. Triginelli and Carlos G. Ferreira

    Article first published online : 10 MAR 2014, DOI: 10.1002/cncr.28471

  11. Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer

    Cancer

    Volume 121, Issue 15, August 1, 2015, Pages: 2570–2577, Peter C. Lo, Suzanne E. Dahlberg, Mizuki Nishino, Bruce E. Johnson, Lecia V. Sequist, David M. Jackman, Pasi A. Jänne and Geoffrey R. Oxnard

    Article first published online : 15 APR 2015, DOI: 10.1002/cncr.29397

  12. Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer

    Cancer

    Karen L. Reckamp, Marianna Koczywas, Mihaela C. Cristea, Jonathan E. Dowell, He-Jing Wang, Brian K. Gardner, Ginger L. Milne, Robert A. Figlin, Michael C. Fishbein, Robert M. Elashoff and Steven M. Dubinett

    Article first published online : 29 MAY 2015, DOI: 10.1002/cncr.29480

  13. You have free access to this content
    Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor

    Cancer

    Volume 119, Issue 24, 15 December 2013, Pages: 4325–4332, Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka, Jumpei Takeshita, Kosuke Tanaka, Shigeki Nanjo, Shiro Fujita, Reiko Kaji, Yukihiro Imai, Kazuya Monden, Takeshi Matsumoto, Kazuma Nagata, Kyoko Otsuka, Ryo Tachikawa, Keisuke Tomii, Kei Kunimasa, Masahiro Iwasaku, Akihiro Nishiyama, Tadashi Ishida and Yoshihiro Nishimura

    Article first published online : 16 SEP 2013, DOI: 10.1002/cncr.28364

  14. You have full text access to this OnlineOpen article
    Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib

    Cancer

    Volume 120, Issue 24, December 15, 2014, Pages: 3896–3901, Boe S. Sorensen, Lin Wu, Wen Wei, Julie Tsai, Britta Weber, Ebba Nexo and Peter Meldgaard

    Article first published online : 7 AUG 2014, DOI: 10.1002/cncr.28964

  15. Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Cancer

    Volume 121, Issue 7, April 1, 2015, Pages: 997–1007, Kathryn M. Field, Justin T. Jordan, Patrick Y. Wen, Mark A. Rosenthal and David A. Reardon

    Article first published online : 26 SEP 2014, DOI: 10.1002/cncr.28935

  16. You have free access to this content
    The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancer

    Cancer

    Volume 120, Issue 15, August 1, 2014, Pages: 2299–2307, Mingchuan Zhao, Yishi Zhang, Weijing Cai, Jiayu Li, Fei Zhou, Ningning Cheng, Ruixin Ren, Chao Zhao, Xuefei Li, Shengxiang Ren, Caicun Zhou and Fred R. Hirsch

    Article first published online : 15 APR 2014, DOI: 10.1002/cncr.28725

  17. You have free access to this content
    Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: A prospective, single-institute study

    Cancer

    Volume 120, Issue 10, 15 May 2014, Pages: 1471–1481, Masakuni Serizawa, Yasuhiro Koh, Hirotsugu Kenmotsu, Mitsuhiro Isaka, Haruyasu Murakami, Hiroaki Akamatsu, Keita Mori, Masato Abe, Isamu Hayashi, Tetsuhiko Taira, Tomohiro Maniwa, Toshiaki Takahashi, Masahiro Endo, Takashi Nakajima, Yasuhisa Ohde and Nobuyuki Yamamoto

    Article first published online : 3 APR 2014, DOI: 10.1002/cncr.28604

  18. You have full text access to this OnlineOpen article
    Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

    Cancer

    Volume 120, Issue 9, 1 May 2014, Pages: 1290–1314, Brenda K. Edwards, Anne-Michelle Noone, Angela B. Mariotto, Edgar P. Simard, Francis P. Boscoe, S. Jane Henley, Ahmedin Jemal, Hyunsoon Cho, Robert N. Anderson, Betsy A. Kohler, Christie R. Eheman and Elizabeth M. Ward

    Article first published online : 16 DEC 2013, DOI: 10.1002/cncr.28509

  19. You have free access to this content
    Population-based cancer registries for quality-of-life research

    Cancer

    Volume 119, Issue S11, 1 June 2013, Pages: 2109–2123, Melissa S. Y. Thong, Floortje Mols, Kevin D. Stein, Tenbroeck Smith, Jan-Willem W. Coebergh and Lonneke V. van de Poll-Franse

    Article first published online : 20 MAY 2013, DOI: 10.1002/cncr.28056

  20. You have free access to this content
    Multidisciplinary approaches to intrahepatic cholangiocarcinoma

    Cancer

    Volume 119, Issue 22, 15 November 2013, Pages: 3929–3942, Shishir K. Maithel, T. Clark Gamblin, Ihab Kamel, Celia Pamela Corona-Villalobos, Melanie Thomas and Timothy M. Pawlik

    Article first published online : 20 AUG 2013, DOI: 10.1002/cncr.28312